These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 29117311)

  • 21. The promise of ketamine for treatment-resistant depression: current evidence and future directions.
    DeWilde KE; Levitch CF; Murrough JW; Mathew SJ; Iosifescu DV
    Ann N Y Acad Sci; 2015 May; 1345(1):47-58. PubMed ID: 25649308
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Proceed with caution: off-label ketamine treatment for major depressive disorder.
    Sisti D; Segal AG; Thase ME
    Curr Psychiatry Rep; 2014 Dec; 16(12):527. PubMed ID: 25308395
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Ketamine's antidepressant effect: focus on ketamine mechanisms of action].
    De Maricourt P; Jay T; Goncalvès P; Lôo H; Gaillard R
    Encephale; 2014 Feb; 40(1):48-55. PubMed ID: 24434007
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Ketamine helps a third of patients with treatment resistant depression, finds small UK study.
    Torjesen I
    BMJ; 2014 Apr; 348():g2576. PubMed ID: 24699320
    [No Abstract]   [Full Text] [Related]  

  • 25. Repeated S-ketamine infusions in therapy resistant depression: a case series.
    Segmiller F; Rüther T; Linhardt A; Padberg F; Berger M; Pogarell O; Möller HJ; Kohler C; Schüle C
    J Clin Pharmacol; 2013 Sep; 53(9):996-8. PubMed ID: 23893490
    [No Abstract]   [Full Text] [Related]  

  • 26. [Ketamine--a new treatment option for therapy-resistant depression].
    Köhler S; Betzler F
    Fortschr Neurol Psychiatr; 2015 Feb; 83(2):91-7. PubMed ID: 25723773
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Promoting the Discussion of the Beneficial Effects of Ketamine to Treat Refractory Depression.
    Ghosh P; Viswanath O
    Psychopharmacol Bull; 2019 Feb; 49(1):98-99. PubMed ID: 30858644
    [No Abstract]   [Full Text] [Related]  

  • 28. Single-dose ketamine followed by daily D-Cycloserine in treatment-resistant bipolar depression.
    Kantrowitz JT; Halberstam B; Gangwisch J
    J Clin Psychiatry; 2015 Jun; 76(6):737-8. PubMed ID: 26132675
    [No Abstract]   [Full Text] [Related]  

  • 29. Effect of baseline anxious depression on initial and sustained antidepressant response to ketamine.
    Ionescu DF; Luckenbaugh DA; Niciu MJ; Richards EM; Slonena EE; Vande Voort JL; Brutsche NE; Zarate CA
    J Clin Psychiatry; 2014 Sep; 75(9):e932-8. PubMed ID: 25295436
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Neurocognitive effects of ketamine and association with antidepressant response in individuals with treatment-resistant depression: a randomized controlled trial.
    Murrough JW; Burdick KE; Levitch CF; Perez AM; Brallier JW; Chang LC; Foulkes A; Charney DS; Mathew SJ; Iosifescu DV
    Neuropsychopharmacology; 2015 Mar; 40(5):1084-90. PubMed ID: 25374095
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A randomized trial of an N-methyl-D-aspartate antagonist in treatment-resistant major depression.
    Zarate CA; Singh JB; Carlson PJ; Brutsche NE; Ameli R; Luckenbaugh DA; Charney DS; Manji HK
    Arch Gen Psychiatry; 2006 Aug; 63(8):856-64. PubMed ID: 16894061
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Frontiers in Therapy of Treatment-Resistant-Depression: A Future Role of Ketamine?
    Kwak S; Tiller D; Tucker P
    J Okla State Med Assoc; 2015 Mar; 108(3):88-9. PubMed ID: 26242015
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Considerations for use of ketamine to treat depression in Australia and New Zealand.
    Bayes A; Dong V; Loo C
    Aust N Z J Psychiatry; 2019 Nov; 53(11):1117-1120. PubMed ID: 31364369
    [No Abstract]   [Full Text] [Related]  

  • 34. Oral ketamine augmentation for chronic suicidality in treatment-resistant depression.
    De Gioannis A; De Leo D
    Aust N Z J Psychiatry; 2014 Jul; 48(7):686. PubMed ID: 24452289
    [No Abstract]   [Full Text] [Related]  

  • 35. [Ketamine for treatment of acute depression].
    Hjerrild S; Bjerre J; Pedersen RH; Videbech P
    Ugeskr Laeger; 2013 Sep; 175(37):2090-3. PubMed ID: 24011203
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Ketamine-induced affective switch in a patient with treatment-resistant depression.
    Banwari G; Desai P; Patidar P
    Indian J Pharmacol; 2015; 47(4):454-5. PubMed ID: 26288483
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Role of Ketamine in Severe Depression with suicidal ideation - Insights from a Case Study.
    Gurnani T; Khurshid KA
    Asian J Psychiatr; 2017 Oct; 29():112-113. PubMed ID: 29061405
    [No Abstract]   [Full Text] [Related]  

  • 38. Ketamine: repurposing and redefining a multifaceted drug.
    Potter DE; Choudhury M
    Drug Discov Today; 2014 Dec; 19(12):1848-54. PubMed ID: 25224017
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Transient resolution of treatment-resistant posttraumatic stress disorder following ketamine infusion.
    D'Andrea D; Andrew Sewell R
    Biol Psychiatry; 2013 Nov; 74(9):e13-4. PubMed ID: 23706680
    [No Abstract]   [Full Text] [Related]  

  • 40. Maintaining the initial clinical response after ketamine in bipolar and unipolar depression: an important next-step challenge.
    Iosifescu DV
    J Clin Psychiatry; 2015 Jun; 76(6):738-40. PubMed ID: 26132676
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.